Interacting Drugs |
Ribavirin vs Reverse Transcriptase Inhibitors (Nucleoside) |
Security Level |
|
Mechanism |
Reverse Transcriptase Inhibitors (Nucleoside): Ribavirin may enhance the hepatotoxic effect of Reverse Transcriptase Inhibitors (Nucleoside). Lactic acidosis may occur. |
Management |
Consider therapy modification |
Ribavirin vs Reverse Transcriptase Inhibitors (Nucleoside)
Post Review about Ribavirin vs Reverse Transcriptase Inhibitors (Nucleoside) Click here to cancel reply.
Other Interactions of Ribavirin
Other Interactions of Reverse Transcriptase Inhibitors (Nucleoside)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.